Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:45 AM
Ignite Modification Date:
2025-12-25 @ 3:45 AM
NCT ID:
NCT05758402
Eligibility Criteria:
Inclusion Criteria:
* Patient who is \>= 19 years of age at the time of study enrollment
* Patient who had an established diagnosis of PsO based upon clinical evidence and documented medical history
* Patient who is moderate to severe PsO (Psoriasis Area and Severity Index (PASI) score \>= 10)
* Patient who is willing and able to comply with study procedures
* Patient who is able to provide the informed consent form (ICF)
Exclusion Criteria:
* Patients who have formal pre-existing diagnosis of PsA
* Patients who have ever received treatment with biologic Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
* Patients who currently receive systemic glucocorticoids
* Patients who currently receive opioid analgesics
* Patients who has other known pre-existing dermatological or rheumatological diseases:
* Non-plaque psoriasis
* Rheumatoid arthritis
* Osteoarthritis
* Gout
* Reactive arthritis
* Ankylosing spondylitis
* Axial spondyloarthritis
* Enteropathic arthritis
* Plantar fasciitis
* Systemic lupus erythematosus (SLE)
* Female patients who are pregnant
* Patients who are participating in other interventional clinical trials
* Patients who have already had PsA screening via screening questionnaires or imaging
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT05758402
Study Brief:
Protocol Section:
NCT05758402